Symposium lecture (I) – Basic Science (11:45 – 12:30)
Professor Wei JIA
Chair Professor, Molecular and Systems Metabolism,
Vivian Taam Wong Professor in Integrative Medicine
Department of Pharmacology & Pharmacy,
Faculty of Medicine, The University of Hong Kong
Topic: Hyocholic Acid Regulates Glucose and Lipid Metabolism through Gut-liver Axis
Biography:
Professor Wei JIA is a distinguished Chair Professor of Molecular and Systems Metabolism and holds the Vivian Taam Wong Professorship in Integrative Medicine at the Department of Pharmacology and Pharmacy, HKU. Prof. JIA earned his M.S. and Ph.D. degrees in radiopharmaceutical science from the University of Missouri-Columbia.
Prof. JIA is a distinguished member of the Academia Europaea, having been elected to the Physiology & Neuroscience Section in 2023. His current research focuses on elucidating the complex molecular pathways linking metabolic disturbances in gut microbial-host co-metabolism to the development of metabolic disorders and gastrointestinal cancers. Additionally, Professor Jia leads a renowned translational medicine laboratory equipped with a state-of-the-art metabolomics platform. With nearly three decades of experience, his lab specializes in the quantitative analysis of endogenous small-molecule metabolites and trace elements from diverse biological samples.
SPEAKERS
Symposium lecture (II) – Clinical (14:00 – 14:45)
Topic: MASLD: Pathogenesis, Assessment, and
Therapeutic Advances
Biography:
Professor Vincent Wai Sun WONG holds the position of Mok Hing Yiu Professor of Medicine and serves as the Head (Academic) of the Division of Gastroenterology and Hepatology at The Chinese University of Hong Kong. His research primarily revolves around steatotic liver disease and liver fibrosis, with a particular focus on the development and application of non-invasive tests for screening, diagnosis and prognostication. Notably, he contributed to the writing committee responsible for formulating the guidelines of the Asian Pacific Association for the Study of the Liver, American Gastroenterological Association and the European Association for the Study of the Liver. He has authored more than 650 publications in international medical journals. His h-index by Google Scholar is 135 as of March 2025. He holds the position of associate editor for the Journal of Hepatology and serves as an editorial board member for renowned publications such as Gastroenterology, JHEP Reports, and Clinical and Molecular Hepatology. He was the president of the Hong Kong Association for the Study of Liver Diseases from 2015 to 2017 and the Chairman of the Specialty Board of Gastroenterology and Hepatology at the Hong Kong College of Physicians from 2022 to 2025. He has been honoured with research awards from esteemed organizations such as the Asian Pacific Association for the Study of the Liver, Asian Pacific Digestive Week Federation, British Society of Gastroenterology, Hong Kong College of Physicians, the Health Bureau of the Hong Kong SAR Government, and the Ministry of Science and Technology and the Ministry of Education of China.
Professor Vincent Wai Sun WONG
Professor, Department of Medicine and Therapeutics,
The Chinese University of Hong Kong
Dr. Tai Pang IP
Chairperson, OSHK Task Gorup on Formulation of Management Guideline,
Osteoporosis Society of Hong Kong
Topic: Targets of Anti-Osteoporosis Therapy – An Updated Clinical Osteoporosis Management Guideline
Biography:
Dr. Tai Pang IP graduated from the University of Hong Kong in 1989. He received his specialist training in endocrinology at Queen Mary Hospital, Hong Kong and the Garvan Institute of Medical Research, Sydney, Australia (Feb-Aug, 1994) and became a Specialist in Endocrinology, Diabetes & Metabolism in 1997.
Dr. IP is one of the pioneers in the provision of clinical management to osteoporosis patients in Hong Kong. He established the Osteoporosis Clinic in Tung Wah Eastern Hospital in 1997, which was one of the earliest osteoporosis clinics in the public sector. He was the founding Honorary Secretary of the Osteoporosis Society of Hong Kong (OSHK) in 2002 and elected the President of OSHK from 2010-2012. He was also the elected Advisory Council Member, Asia-Pacific Regional Advisory Council, International Osteoporosis Foundation from 2010-2014 and nominated as National Committee Member of the Asian Federation of Osteoporosis Societies (AFOS) from 2010-2012. He is currently an invited Scientific Advisory Group Member of the Asia Pacific Consortium on Osteoporosis (APCO) since 2021.
Dr. IP is a well-known physician in the clinical therapeutics of osteoporosis and diabetes. He has been very active in promoting personalized approach in the pharmacological treatment of osteoporosis and diabetes to the profession. In the past 30 years, Dr. Ip has delivered more than 350 lectures on osteoporosis & diabetes in local, regional and international scientific meetings. He was the lead author of the 2013 and the recently published 2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong.
Dr. IP had served in the public sector for 36 years from July 1989 until he had his formal retirement in July 2025 from the post of Consultant of the Department of Medicine, Tung Wah Hospital. Currently he had entered into private practice as a Consultant Specialist in Endocrinology & Diabetes of the Pedder HealthCare.